University Hospitals and Case Western Reserve fund magnetic resonance fingerprinting research

Wells Messersmith named director of CU Anschutz Cancer Center

Wells Messersmith was named director of the University of Colorado Anschutz Cancer Center, effective Oct. 1.

October 30, 2026

University of Illinois’ Andrei Gartel receives NCI grant to study AML

NCI awarded a two-year $422,000 grant to University of Illinois Cancer Center member Andrei Gartel to examine what might influence differences in outcomes for some patients with acute myeloid leukemia, an aggressive blood cancer with persistently poor outcomes in which relapse is common.

October 30, 2026

Vol.52 No.40

Perspective

California’s Prop 38 is an historic approach to funding medical research, immunology
The $8.4B bond makes a long-term investment in a field with life-saving power

Throughout my career as a physician and scientist, I’ve seen ideas once considered impossible become breakthroughs that save lives. They happened because talented scientists had the resources, institutions, and sustained support to pursue ambitious ideas. Most importantly, they knew patients could not afford to wait.

October 23, 2026

Vol.52 No.39

By Arie S. Belldegrun

Cancer Policy

Letai announces: NCI met FY26 goal of full funding payout

In a post on NCI’s LinkedIn, NCI Director Anthony Letai confirmed that the institute has fully awarded and paid out all of its grant funding for the Fiscal Year 2026.

October 16, 2026

Vol.52 No.38

By Claire Marie Porter

In Brief

Moffitt advances patient avatar technologies through $15M federal research initiative

Moffitt Cancer Center is advancing patient avatar technologies through a $15 million federally funded research initiative in collaboration with the Murtha Cancer Center Research Program at the Uniformed Services University of the Health Sciences in Bethesda, Maryland.

October 16, 2026

Vol.52 No.38

Podcast

Anthony Letai reflects on Year One as NCI Director: “The NCI is in business”

“I don’t know of a single grant that left my desk that was not approved and funded,” NCI Director Anthony G. Letai said on this episode of The Cancer Letter Podcast. https://open.spotify.com/episode/2PFYGwliBDYEbxBXFd9MtB?si=95DNBAy0QGSKBX31_uETEA This episode is available on Spotify, Apple Podcasts, and Youtube. Letai recapped his first year as NCI director in conversation with Paul Goldberg,...

October 07, 2026

University Hospitals and Case Western Reserve fund magnetic resonance fingerprinting research

YOU MAY BE INTERESTED IN

Wells Messersmith named director of CU Anschutz Cancer Center

University of Illinois’ Andrei Gartel receives NCI grant to study AML

California’s Prop 38 is an historic approach to funding medical research, immunology
The $8.4B bond makes a long-term investment in a field with life-saving power

Letai announces: NCI met FY26 goal of full funding payout

Moffitt advances patient avatar technologies through $15M federal research initiative

Anthony Letai reflects on Year One as NCI Director: “The NCI is in business”

Renew today!

Subscriber content

Never miss an issue!

Login

University Hospitals and Case Western Reserve fund magnetic resonance fingerprinting research

YOU MAY BE INTERESTED IN

Wells Messersmith named director of CU Anschutz Cancer Center

University of Illinois’ Andrei Gartel receives NCI grant to study AML

California’s Prop 38 is an historic approach to funding medical research, immunologyThe $8.4B bond makes a long-term investment in a field with life-saving power

Letai announces: NCI met FY26 goal of full funding payout

Moffitt advances patient avatar technologies through $15M federal research initiative

Anthony Letai reflects on Year One as NCI Director: “The NCI is in business”

Never miss an issue!

Login

California’s Prop 38 is an historic approach to funding medical research, immunology
The $8.4B bond makes a long-term investment in a field with life-saving power